Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 466K - 466K
Notice Type:
Contract award notice
Published Date:
30 July 2021
Closing Date:
Location(s):
FRH01 Côtes-d’Armor (FR FRANCE)
Description:
Médicaments de cancérologie — Pemetrexed 2 du 1.8.2021 au 31.5.2022, reconductible jusqu'au 31.5.2024

Médicaments de cancérologie — Pemetrexed 2 du 1.8.2021 au 31.5.2022, reconductible jusqu'au 31.5.2024.


1 lot: Pemetrexed

Pemetrexed.

Awarded to:
Pemetrexed
Teva Santé, La Défense Cedex (FR)
Download full details as .pdf
The Buyer:
CHG de Saint-Brieuc
CPV Code(s):
33600000 - Pharmaceutical products